Morgan Stanley Maintains Overweight on Hinge Health, Raises Price Target to $131
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $117 to $131.
Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $117 to $131.